EPCAM and lung adenocarcinoma: We hypothesize that lncCDH5-3:3 controls CDH1 and, as a consequence, EPCAM expression, which encodes EpCAM, one more protein involved in the regulation of EMT, thereby exerting an important influence on the progression of lung adenocarcinoma [16].